共 11 条
[1]
Withdrawal of statin treatment abrogates stroke protection in mice. Gertz K,Laufs U,Lindauer U,et al. Stroke . 2003
[2]
3-Hydrooxy-3-methylglutaryl CoA reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells role of geranylgeranylation and Rho protein. Essig M,Nguyen G,Prie d,et al. Circulation Research . 1998
[3]
Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Eto M,Kozai T,Cosentino F,et al. Circulation . 2002
[4]
High dose of atorvastatin do not affect activity of prothrombinases with acute coronary syndromes. Olivotti L,Ghiglitti G,Spallarossa P,et al. Blood Coagulation and Fibrinolysis . 2002
[5]
Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator and C reaction protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study): fluvastatin alone and in combination treatment. Cortellaro M,Cofrancesco E,Boschetti C,et al. Thrombosis and Haemostasis . 2000
[6]
Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Son JW,Koh KK,Ahn JY,et al. International Journal of Cardiology . 2003
[7]
Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels. Musial J,Undas A,Undas R,et al. Thrombosis and Haemostasis . 2001
[8]
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. Seljeflot I,Tonstad S,Hjermann I,Arnesen H. Tromb Research . 2002
[9]
Statin effects beyond lipid lowering: are they clinically relevant. Bonetti PO,Lerman LO,Napoli C,et al. European Heart Journal . 2003
[10]
Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Dangas G,Smith DA,Unger AH,et al. Thrombosis and Haemostasis . 2000